Pfizer COVID pill approved in Japan, following Merck treatment

Nikkei Asia | Feb. 10, 2022, 5:05 p.m. | Original

TOKYO -- Japan's health ministry on Thursday approved Pfizer's COVID-19 pill Paxlovid for patients with mild to moderate symptoms, making it the second such oral medication to receive the fast-track treatment.

Collapse of Nvidia deal costs SoftBank an Arm and a leg World's largest pension fund should create safe space for ESG dissent